Anika Therapeutics Inc (ANIK) Directors and Executive Officers - CSIMarket
CSIMarket
 
Anika Therapeutics Inc   (NASDAQ: ANIK)

Anika Therapeutics Inc

Officers & Directors


1. Cheryl R. Blanchard, Ph.D. - President and Chief Executive Officer
Biography: [Link](https://www.anikatherapeutics.com/about-us/management-team/cheryl-blanchard/)

2. Michael Levitz - Executive Vice President, Chief Financial Officer and Treasurer
Biography: [Link](https://www.anikatherapeutics.com/about-us/management-team/michael-levitz/)

3. Stephen O. Richard - Director

4. Sheryl L. Conley - Director

5. Jeffery S. Thompson - Director

6. Glenn R. Larsen, Ph.D. - Director

7. Susan L.N. Vogt - Director

8. Gary P. Fischetti - Director

9. John B. Henneman, III - Director, Chairman of the Board

10. Ian McLeod - Vice President, Chief Accounting Officer

11. Thomas M. Finnerty - Senior Vice President, General Counsel, and Secretary
Biography: [Link](https://www.anikatherapeutics.com/about-us/management-team/thomas-finnerty/)

12. Charles H. Sherwood, M.D. - Chairman of the Board of Directors
Biography: [Link](https://www.anikatherapeutics.com/about-us/board-of-directors/charles-h-sherwood/)

13. Sylvia Cheung - Senior Vice President, Global Marketing and Business Development
Biography: [Link](https://www.anikatherapeutics.com/about-us/management-team/sylvia-cheung/)

14. Joseph Darling - Senior Vice President, Operations and Supply Chain
Biography: [Link](https://www.anikatherapeutics.com/about-us/management-team/joseph-darling/)

15. Joseph Bower - Professor, Harvard Business School
Biography: [Link](https://www.anikatherapeutics.com/about-us/board-of-directors/joseph-bower/)

16. Mira Sahney Chaurushiya - Vice President, Jefferies LLC
Biography: [Link](https://www.anikatherapeutics.com/about-us/board-of-directors/mira-sahney-chaurushiya/)

17. Stephen W. Green - President, and CEO, Sarepta Therapeutics
Biography: [Link](https://www.anikatherapeutics.com/about-us/board-of-directors/stephen-w-green/)

18. Martha Goldberg Aronson - Senior Advisor and former Chief Financial Officer, J. Crew Group, Inc.
Biography: [Link](https://www.anikatherapeutics.com/about-us/board-of-directors/martha-goldberg-aronson/)

19. Richard Hague - Former Chief Financial Officer and Treasurer, Genzyme Corporation
Biography: [Link](https://www.anikatherapeutics.com/about-us/board-of-directors/richard-hague/)

20. Christopher M. Larkin - President and CEO, Qualigen Therapeutics, Inc.
Biography: [Link](https://www.anikatherapeutics.com/about-us/board-of-directors/christopher-m-larkin/) ,

Anika Therapeutics Inc currently has 21 employees.

  News about Anika Therapeutics Inc Key Personnel

Anika Therapeutics Inc. Strategically Divests Subsidiaries to Focus on Profitable OA Pain Management Amid Financial Losses,

Anika Therapeutics Inc. Strategic Shift Amid Financial ChallengesIn a strategic maneuver aligned with its long-term vision, Anika Therapeutics Inc. a leading name in joint preservation and early intervention orthopedics, has announced a significant update to its business strategy. This includes the sale of its subsidiary, Arthrosurface, and the impending divestment of Parcus Medical. This strategic refocus aims to enhance their portfolio in profitable, hyaluronic acid-driven osteoarthritis (OA) pain management and to capitalize on the growth potential of regenerative solutions. Facts and Developments1. Strategic Divestitures: - Anika Therapeutics is divesting from Arthrosurface and plans to sell Parcus...






ANIK Management Effectiveness ANIK Revenue per Employee ANIK Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.